SCHEMBL7065249

SCHEMBL7065249

CNC(=O)[C@@H](N)Cc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 2/20 0.56
LMNA P02545 1/20 0.55
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
MMP1 P03956 1/20 0.47
MMP3 P08254 1/20 0.47
DPP4 P27487 1/20 0.46
DPP8 Q6V1X1 1/20 0.46
DPP9 Q86TI2 1/20 0.46
DPP7 Q9UHL4 1/20 0.46
ALDH1A1 P00352 3/20 0.46
LOXL2 Q9Y4K0 1/20 0.46
RECQL P46063 1/20 0.46
HSD17B10 Q99714 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 1/20 0.46
TP53 P04637 1/20 0.46
RAB9A P51151 1/20 0.46
MC4R P32245 1/20 0.46
MAPK1 P28482 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7065251 1.00 MMP2 (0.56) MMP2LMNAMEN1KMT2AMMP1
SCHEMBL6798022 1.00 MMP2 (0.56) MMP2LMNAMEN1KMT2AMMP1
Hydrochloric Acid SCHEMBL6803383 0.98 MMP2 (0.55) MMP2LMNAMEN1KMT2AMMP1
Hydrochloric Acid SCHEMBL6803379 0.98 MMP2 (0.55) MMP2LMNAMEN1KMT2AMMP1
SCHEMBL4930706 0.86 CSK (0.59) MMP2LMNAMEN1KMT2ADPP4
SCHEMBL4930693 0.86 CSK (0.59) MMP2LMNAMEN1KMT2ADPP4
SCHEMBL7336941 0.84 MMP2 (0.56) MMP2LMNAMEN1KMT2AMMP1
SCHEMBL7365536 0.84 MMP2 (0.56) MMP2LMNAMEN1KMT2AMMP1
SCHEMBL7336938 0.84 MMP2 (0.56) MMP2LMNAMEN1KMT2AMMP1
SCHEMBL16131783 0.84 LOXL2 (0.52) MMP2LMNAMEN1KMT2ADPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098692-B1 PROTECTIVE COVER FOR A FAN-TYPE COOLING UNIT GORE W L & ASS GMBH (DE) 2003-05-28 EP claimed
EP-1313696-A2 AMINO(OXO)ACETIC ACID PROTEIN TYROSINE PHOSPHATASE INHIBITORS ABBOTT LABORATORIES (US) 2003-05-28 EP disclosed
US-20020035137-A1 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors ABBOTT LABORATORIES 2002-03-21 US disclosed
WO-2002018323-A2 AMINO(OXO)ACETIC ACID PROTEIN TYROSINE PHOSPHATASE INHIBITORS ABBOTT LABORATORIES (US) 2002-03-07 WO disclosed
US-5280027-A Quinazoline containing compound IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020035137-A1 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors PPM1A, PTPRO, PTP4A1 MMP2 3038/4885LMNA 4772/4885MEN1 3065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.